BCL2 and neoplasm: When we compared the mutation profiles from diagnosis with those from relapse or progression using paired tumor samples from four patients, truncated or nontruncated mutations were frequently found in CREBBP and BCL2 at the time of diagnosis and relapse (Figure 5(a)).